Pembrolizumab in Treating Patients With Bladder Cancer Undergoing Radical Cystectomy

Clinical trial NCT03319745 · COMPLETED

Trial details

NCT number: NCT03319745
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage I Bladder Cancer AJCC v8 Stage II Bladder Cancer AJCC v8 Stage III Bladder Cancer AJCC v8 Stage IIIA Bladder Cancer AJCC v8 Stage IIIB Bladder Cancer AJCC v8

Start date: 2018-01-11
Primary completion: 2023-05-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.